Page 81 - Read Online
P. 81

Author Instructions

           from ethics approval, related information (e.g., name of the ethics committee granting the exemption and the reason for
           the exemption) must be listed. Further documentation on ethics should also be prepared, as editors may request more
           detailed information. Manuscripts with suspected ethical problems will be investigated according to COPE Guidelines.

           3.1.1 Consent to Participate
           For all studies involving human subjects, informed consent to participate in the studies must be obtained from
           participants, or their parents or legal guardians for children under 16. Statements regarding consent to participate should
           be included in a declaration statement of Ethical Approval and Consent to Participate in the manuscript. If informed
           consent is not required, the name of the ethics committee granting the exemption and the reason for the exemption must
           be listed. If any ethical violation is found at any stage of publication, the issue will be investigated seriously based on
           COPE Guidelines.

           3.1.2 Consent for Publication
           All articles published by OAE are freely available on the Internet. All manuscripts that include individual participants’
           data in any form (i.e., details, images, videos, etc.) will not be published without Consent for Publication obtained from
           that person(s), or for children, their parents or legal guardians. If the person has died, Consent for Publication must be
           obtained from the next of kin. Authors must add a declaration statement of Consent for Publication in the manuscript,
           specifying written informed consent for publication has been obtained.
           3.1.3. Trial Registration
           OAE requires all authors to register all relevant clinical trials that are reported in manuscripts submitted. OAE follows the
           World Health Organization (WHO)’s definition of clinical trials: “A clinical trial is any research study that prospectively
           assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on
           health outcomes. Interventions include but are not restricted to drugs, cells, other biological products, surgical procedures,
           radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.”.
           In line with International Committee of Medical Journal Editors (ICMJE) recommendation, OAE requires the registration
           of clinical trials in a public trial registry at or before the time of first patient enrollment. OAE accepts publicly accessible
           registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform or in
           ClinicalTrials.gov. The trial registration number should be listed at the end of the Abstract section.
           Secondary data analyses of primary (parent) clinical trials should not be registered as a new clinical trial, but rather
           reference the trial registration number of the primary trial.
           Editors of OAE journals will consider carefully whether studies failed to register or had an incomplete trial registration.
           Because of the importance of prospective trial registration, if there is an exception to this policy, trials must be registered
           and the authors should indicate in the publication when registration was completed and why it was delayed. Editors will
           publish a statement indicating why an exception was allowed. Please note such exceptions should be rare, and authors
           failing to prospectively register a trial risk its inadmissibility to OAE journals.
           Authors who are not sure whether they need trial registration may refer to ICMJE FAQs for further information.
           3.2. Research Involving Animals
           Experimental research on animals should be approved by an appropriate ethics committee and must comply with
           institutional, national, or international guidelines. OAE encourages authors to comply with the AALAS Guidelines,
           the ARRIVE Guidelines, and/or the ICLAS Guidelines, and obtain prior approval from the relevant ethics committee.
           Manuscripts must include a statement indicating that the study has been approved by the relevant ethical committee and
           the whole research process complies with ethical guidelines. If a study is granted an exemption from requiring ethics
           approval, the name of the ethics committee granting the exemption and the reason(s) for the exemption should be detailed.
           Editors will take account of animal welfare issues and reserve the right to reject a manuscript, especially if the research
           involves protocols that are inconsistent with commonly accepted norms of animal research.

           3.3. Research Involving Cell Lines
           Authors must describe what cell lines are used and their origin so that the research can be reproduced. For established cell
           lines, the provenance should be stated and references must also be given to either a published paper or to a commercial
           source. For de novo cell lines derived from human tissue, appropriate approval from an institutional review board or
           equivalent ethical committee, and consent from the donor or next of kin, should be obtained. Such statements should be
           listed on the Declaration section of Ethical Approval and Consent to Participate in the manuscript.
           Further information is available from the International Cell Line Authentication Committee (ICLAC). OAE recommends
           that authors check the NCBI database for misidentification and contamination of human cell lines.
           3.4. Publication Ethics Statement
           The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to
           guarantee to add high-quality scientific works to the field of scholarly publication.
           Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like,
   76   77   78   79   80   81   82   83   84   85   86